# Molecular Imaging of NET Using [C-11]MRB-PET in MS

> **NCT03207464** · PHASE1,PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 19 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** [C-11]Methylreboxetine

## Key facts

- **NCT ID:** NCT03207464
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-10-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03207464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03207464, "Molecular Imaging of NET Using [C-11]MRB-PET in MS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03207464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*